Point-of-care testing (POCT) includes professional-grade in vitro diagnostic tests completed in close proximity to patients. By performing diagnostic tests closer to patients and obtaining results ...

The global point-of-care testing (POCT) market is driven by rising patient demand, technological innovation, and supportive regulatory frameworks. Rapid diagnostics, enhanced chronic disease ...

Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.

This presentation will briefly cover point-of-care testing (POCT) from a historical standpoint. (What are we doing and why did we decide to do it this way?) This presentation will incorporate ...

Large scale deployment of rapid, low-cost, hand-held point of care testing devices for diagnosing infectious diseases is critical for improving global health. Recent advances in engineering and ...

Point-of-care testing in community pharmacies is becoming more common, according to a new report by the International Pharmaceutical Federation, which also cited challenges that remain to be addressed ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy To put it another way ...

WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced findings from its second annual “Point of Care ...

Point-of-care testing (POCT) is growing in popularity as a means of delivering faster turnaround time of test results closer to the patient. This session will review the latest recommendations and ...